A citation-based method for searching scientific literature

M H Little, K A Williamson, M Mannens, A Kelsey, C Gosden, N D Hastie, V van Heyningen. Hum Mol Genet 1993
Times Cited: 127







List of co-cited articles
824 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


WT-1 is required for early kidney development.
J A Kreidberg, H Sariola, J M Loring, M Maeda, J Pelletier, D Housman, R Jaenisch. Cell 1993
53

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
K M Call, T Glaser, C Y Ito, A J Buckler, J Pelletier, D A Haber, E A Rose, A Kral, H Yeger, W H Lewis. Cell 1990
49

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
J Pelletier, W Bruening, C E Kashtan, S M Mauer, J C Manivel, J E Striegel, D C Houghton, C Junien, R Habib, L Fouser. Cell 1991
761
48

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
M Gessler, A Poustka, W Cavenee, R L Neve, S H Orkin, G A Bruns. Nature 1990
40

Alternative splicing and genomic structure of the Wilms tumor gene WT1.
D A Haber, R L Sohn, A J Buckler, J Pelletier, K M Call, D E Housman. Proc Natl Acad Sci U S A 1991
577
36

A clinical overview of WT1 gene mutations.
M Little, C Wells. Hum Mutat 1997
275
35

The candidate Wilms' tumour gene is involved in genitourinary development.
K Pritchard-Jones, S Fleming, D Davidson, W Bickmore, D Porteous, C Gosden, J Bard, A Buckler, J Pelletier, D Housman. Nature 1990
803
31

DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
M Little, G Holmes, W Bickmore, V van Heyningen, N Hastie, B Wainwright. Hum Mol Genet 1995
82
31


Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
S Barbaux, P Niaudet, M C Gubler, J P Grünfeld, F Jaubert, F Kuttenn, C N Fékété, N Souleyreau-Therville, E Thibaud, M Fellous,[...]. Nat Genet 1997
492
23


Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.
S H Larsson, J P Charlieu, K Miyagawa, D Engelkamp, M Rassoulzadegan, A Ross, F Cuzin, V van Heyningen, N D Hastie. Cell 1995
435
23

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
J Pelletier, W Bruening, F P Li, D A Haber, T Glaser, D E Housman. Nature 1991
408
23

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.
J F Armstrong, K Pritchard-Jones, W A Bickmore, N D Hastie, J B Bard. Mech Dev 1993
426
21

Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
W Bruening, N Bardeesy, B L Silverman, R A Cohn, G A Machin, A J Aronson, D Housman, J Pelletier. Nat Genet 1992
189
20

Zinc finger point mutations within the WT1 gene in Wilms tumor patients.
M H Little, J Prosser, A Condie, P J Smith, V Van Heyningen, N D Hastie. Proc Natl Acad Sci U S A 1992
178
20

WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins.
J C Reddy, J C Morris, J Wang, M A English, D A Haber, Y Shi, J D Licht. J Biol Chem 1995
147
19

Fine structure analysis of the WT1 gene in sporadic Wilms tumors.
R Varanasi, N Bardeesy, M Ghahremani, M J Petruzzi, N Nowak, M A Adam, P Grundy, T B Shows, J Pelletier. Proc Natl Acad Sci U S A 1994
130
19

An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
D A Haber, A J Buckler, T Glaser, K M Call, J Pelletier, R L Sohn, E C Douglass, D E Housman. Cell 1990
534
18

Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
S Park, A Bernard, K E Bove, D A Sens, D J Hazen-Martin, A J Garvin, D A Haber. Nat Genet 1993
123
17



Mutation and cancer: a model for Wilms' tumor of the kidney.
A G Knudson, L C Strong. J Natl Cancer Inst 1972
680
16

A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
A Sakai, K Tadokoro, H Yanagisawa, S Nagafuchi, N Hoshikawa, T Suzuki, T Kohsaka, T Hasegawa, Y Nakahori, M Yamada. Hum Mol Genet 1993
27
59

Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.
W A Bickmore, K Oghene, M H Little, A Seawright, V van Heyningen, N D Hastie. Science 1992
238
15

Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
P N Baird, N Groves, D A Haber, D E Housman, J K Cowell. Oncogene 1992
88
17

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
V Schumacher, S Schneider, A Figge, G Wildhardt, D Harms, D Schmidt, A Weirich, R Ludwig, B Royer-Pokora. Proc Natl Acad Sci U S A 1997
97
15

Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
J M McDonald, E C Douglass, R Fisher, C F Geiser, C E Krill, L C Strong, D Virshup, V Huff. Cancer Res 1998
79
18



Repression of Pax-2 by WT1 during normal kidney development.
G Ryan, V Steele-Perkins, J F Morris, F J Rauscher, G R Dressler. Development 1995
209
14

Inherited WT1 mutation in Denys-Drash syndrome.
M J Coppes, G J Liefers, M Higuchi, A B Zinn, J W Balfe, B R Williams. Cancer Res 1992
94
14

Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
I A Drummond, S L Madden, P Rohwer-Nutter, G I Bell, V P Sukhatme, F J Rauscher. Science 1992
538
14

Mutations in the Wilms' tumor gene WT1 in leukemias.
L King-Underwood, J Renshaw, K Pritchard-Jones. Blood 1996
120
14

Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
M Gessler, A König, K Arden, P Grundy, S Orkin, S Sallan, C Peters, S Ruyle, J Mandell, F Li. Hum Mutat 1994
94
14

Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
B Klamt, A Koziell, F Poulat, P Wieacker, P Scambler, P Berta, M Gessler. Hum Mol Genet 1998
236
13

RNA binding by the Wilms tumor suppressor zinc finger proteins.
A Caricasole, A Duarte, S H Larsson, N D Hastie, M Little, G Holmes, I Todorov, A Ward. Proc Natl Acad Sci U S A 1996
181
13

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
N Rahman, L Arbour, P Tonin, J Renshaw, J Pelletier, S Baruchel, K Pritchard-Jones, M R Stratton, S A Narod. Nat Genet 1996
99
13

Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.
M W Nachtigal, Y Hirokawa, D L Enyeart-VanHouten, J N Flanagan, G D Hammer, H A Ingraham. Cell 1998
452
13

DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
I A Drummond, H D Rupprecht, P Rohwer-Nutter, J M Lopez-Guisa, S L Madden, F J Rauscher, V P Sukhatme. Mol Cell Biol 1994
141
13

Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.
A Koufos, P Grundy, K Morgan, K A Aleck, T Hadro, B C Lampkin, A Kalbakji, W K Cavenee. Am J Hum Genet 1989
431
13

The Wilms' tumor suppressor gene WT1 is negatively autoregulated.
H D Rupprecht, I A Drummond, S L Madden, F J Rauscher, V P Sukhatme. J Biol Chem 1994
120
12

Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.
P N Baird, A Santos, N Groves, L Jadresic, J K Cowell. Hum Mol Genet 1992
83
14

Transcriptional repression mediated by the WT1 Wilms tumor gene product.
S L Madden, D M Cook, J F Morris, A Gashler, V P Sukhatme, F J Rauscher. Science 1991
497
12

Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.
F J Rauscher, J F Morris, O E Tournay, D M Cook, T Curran. Science 1990
550
12

Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
C Jeanpierre, E Denamur, I Henry, M O Cabanis, S Luce, A Cécille, J Elion, M Peuchmaur, C Loirat, P Niaudet,[...]. Am J Hum Genet 1998
183
12


Physical and functional interaction between WT1 and p53 proteins.
S Maheswaran, S Park, A Bernard, J F Morris, F J Rauscher, D E Hill, D A Haber. Proc Natl Acad Sci U S A 1993
317
12

The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
K Pritchard-Jones, J Renshaw, L King-Underwood. Hum Mol Genet 1994
51
23

Familial Wilms' tumor: a descriptive study.
N E Breslow, J Olson, J Moksness, J B Beckwith, P Grundy. Med Pediatr Oncol 1996
65
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.